Jan 14, 2026, 08:53 AM by

Jan 14, 2026, 08:53 AM by

IDT and Ansa announced that Ansa’s Clonal DNA and XL Clonal DNA products, ranging from 100 bp to 50 kb, will be made available to IDT customers. This strategic collaboration enables more researchers to design and assemble longer, more complex constructs for next-generation cell and gene therapy discovery, vaccine research, and agrigenomics applications.

Jan 14, 2026, 01:00 AM by User Not Found

Bio-IT World | At the 44th Annual J.P. Morgan Healthcare Conference, 10x Genomics announced a strong ending to 2025. With great anticipation for 2026, 10x Genomics remains centered on their mission on accelerating understanding of biology to advance human health, particularly in the single-cell and spatial biology areas.

Jan 13, 2026, 17:23 PM by User Not Found

Bio-IT World | Jacob Thaysen returned to the J.P. Morgan Healthcare Conference stage Tuesday with a message of momentum: Illumina is back to growth, and clinical sequencing is driving the train. In his third annual presentation as CEO, Thaysen unveiled preliminary fourth quarter results that exceeded expectations and introduced BioInsight, a new business unit aimed at accelerating drug discovery through AI-powered biological insights.

Jan 13, 2026, 08:46 AM by

Jan 13, 2026, 08:46 AM by

Jan 13, 2026, 08:39 AM by User Not Found

Bio-IT World | PacBio president Christian Henry presented at the 44th Annual J.P. Morgan Healthcare Conference with strong fourth quarter growth, breakthrough clinical adoption, and economics that position long-read sequencing as competitive with short reads.

Jan 12, 2026, 19:35 PM by User Not Found

Bio-IT World | Gordon Sanghera, CEO, presented on behalf of Oxford Nanopore Technologies at the 44th Annual J.P. Morgan Healthcare Conference this week in San Francisco. In what he described as his final appearance at JPM as CEO, Sanghera reflected on 20 years of building a company around single-molecule electronic sensing while outlining a growth trajectory that saw the company exceed expectations in 2025.

Jan 12, 2026, 10:09 AM by User Not Found

Bio-IT World | NVIDIA is making a massive push into healthcare and life sciences, announcing a landmark five-year, $1 billion strategic partnership with pharmaceutical giant Eli Lilly alongside major expansions of its biological AI platform at the 2026 J.P. Morgan Healthcare Conference.

Jan 12, 2026, 09:02 AM by

Cycle and Inceptua have announced the expansion of their partnership to make NITYR® tablets available via a Free Goods Programme for eligible patients with HT-1 and AKU to include Morocco and Egypt.

Jan 12, 2026, 09:02 AM by

Jan 12, 2026, 09:02 AM by

Jan 9, 2026, 08:48 AM by

Verista, a leading provider of automation, compliance, and quality solutions for the life sciences industry, announced the acquisition of Integral Solutions. Based in Columbus, OH, Integral Solutions is a life sciences business and technology services firm that specializes in engineering and validation services worldwide. The acquisition enhances Verista’s capabilities in automation, engineering, project management, and validation, enabling the company to deliver further comprehensive support across the full lifecycle of regulated life sciences operations.

Jan 9, 2026, 08:48 AM by

Jan 9, 2026, 08:48 AM by

Jan 9, 2026, 01:00 AM by User Not Found

Bio-IT World | The Bits in Bio Slack-first community has released its fourth annual State of TechBio survey results. Year over year findings include a jump in Claude usage, an increase in daily machine learning work, and a serious cooling of the “Very bullish" sentiment across the broader biotech market.

Jan 8, 2026, 09:13 AM by

Jan 8, 2026, 09:13 AM by

New white paper details key technical milestones and validation of the company’s proprietary, capsule-based platform to accelerate breakthroughs across human health

Jan 8, 2026, 09:13 AM by

● Installations at National Taiwan University and National Cheng Kung University expand Nuclera’s global footprint with first commercial sales in Asia ● System strengthens Taiwan’s capabilities in protein drug discovery research

Jan 7, 2026, 09:18 AM by

PharmaForceIQ has announced its acquisition of Aktana, aligning its cutting-edge digital orchestration platform with the industry’s premier AI-driven field Next-Best-Action (NBA) platform.